CMS proposes eliminating the minimum 10 g/dL Hgb target for ESAs. |
![]() |
Reuters: The U.S. government health plan said last month that it had no plans to change its reimbursement terms for anemia drugs used to treat kidney patients. But in a statement on its website on Friday, the agency proposed retiring a requirement that patients' hemoglobin, or red blood cell, levels be kept above 10 milligrams per deciliter. |